News/November 16, 2026

Study finds inflammation and fibrosis affect heart aging in mouse models — Evidence Review

Published in Aging Cell, by researchers from The Jackson Laboratory

Researched byConsensus— the AI search engine for science

Table of Contents

A new study finds that aging-related inflammation and tissue scarring in the heart are concentrated around the aortic valves and aortic root, rather than distributed evenly throughout the heart. Related research broadly supports these findings and highlights the importance of localized inflammatory and fibrotic processes in cardiac aging, as detailed in this report from The Jackson Laboratory{:target="_blank" rel="noopener noreferrer"}.

  • Multiple studies confirm that cardiac fibrosis and low-grade inflammation increase with age, but the new research provides unique insight by precisely mapping these changes to specific anatomical regions such as the valves and aortic root rather than the heart muscle alone 1 4 11.
  • Prior literature emphasizes the role of immune cells (macrophages) and fibroblasts in age-related fibrosis and inflammation, supporting the new study’s identification of these cell types as key contributors to localized tissue remodeling 1 2 4.
  • While systemic and diffuse cardiac aging effects are well-documented, this study adds granular detail by revealing regional “hotspots,” a concept that aligns with emerging views on the diversity of aging processes in different cardiac structures 2 5 13.

Study Overview and Key Findings

Understanding how and where the heart ages is an urgent issue, as cardiovascular disease risk increases dramatically with age and interventions often target the most affected regions. Previous research into cardiac aging has focused heavily on the heart muscle, particularly the left ventricle, but this new study from The Jackson Laboratory shifts attention to the valves and aortic root—areas often overlooked but essential to heart function. By applying advanced single-cell and spatial mapping techniques in mice, the research team identified anatomical “hotspots” where inflammation and fibrosis accumulate, offering new perspectives that could influence future prevention and treatment strategies for age-related heart disease.

Property Value
Organization The Jackson Laboratory
Journal Name Aging Cell
Authors Nadia Rosenthal, Amalia Sintou
Population Mouse hearts
Methods Animal Study
Outcome Inflammation and tissue scarring in heart regions
Results Inflammation and fibrosis concentrated around heart valves and aortic root.

To contextualize these findings, we searched the Consensus database, which contains over 200 million research papers, for relevant literature. The following search queries were used:

  1. heart aging inflammation fibrosis
  2. aortic root heart valve changes
  3. cardiovascular aging mechanisms studies

Below, we organize key insights from the literature into main topic areas:

Topic Key Findings
How does aging drive inflammation and fibrosis in the heart? - Aging promotes cardiac fibrosis primarily through reduced collagen degradation, increased immune cell infiltration, and activation of pro-fibrotic pathways 1 4 11.
- Chronic low-grade inflammation ("inflamm-aging") is now recognized as a major contributor to cardiovascular risk and is driven by both cellular senescence and immune dysregulation 5 11 13.
Are certain heart regions more susceptible to age-related changes? - The aortic root and heart valves are complex anatomical regions where structural changes can lead to stenosis, regurgitation, or fibrosis 6 9.
- Clinical and experimental evidence suggests that the aortic root and valves often experience age-related thickening, scarring, and functional decline, sometimes independently of changes in heart muscle 10 6.
What are the cellular and molecular mechanisms underlying cardiac aging? - Macrophage and fibroblast interactions, metabolic reprogramming, oxidative stress, and senescence-associated pathways are critical drivers of tissue remodeling and inflammation in the aging heart 2 3 4 13.
- Sex differences exist in the molecular signatures of cardiac aging, and metabolic and immune pathways may be differentially regulated in males and females 3 5.
Can interventions or diagnostics target region-specific cardiac aging? - Lifestyle and pharmacologic interventions (e.g., exercise, caloric restriction, senolytics, anti-inflammatory drugs) may attenuate localized or systemic aging effects in the heart 5 15.
- Non-invasive imaging and molecular diagnostics are being developed to detect early, region-specific changes such as arterial stiffness, valve calcification, or localized fibrosis 15 7.

How does aging drive inflammation and fibrosis in the heart?

The concentration of inflammation and fibrosis in specific heart regions identified in the new study aligns with long-standing evidence that cardiac aging is not a uniform process. Prior research highlights a gradual buildup of collagen, immune cell infiltration, and activation of pro-fibrotic pathways as central mechanisms, with the concept of "inflamm-aging" now central to understanding cardiovascular risk in older adults 1 4 11.

  • Studies report that cardiac fibrosis increases with age, mostly due to impaired collagen breakdown rather than increased synthesis, and is accompanied by immune cell (macrophage) infiltration 1 4.
  • Chronic low-grade inflammation has been recognized as a key mediator of age-related cardiovascular decline, with immune system dysregulation and cellular senescence playing pivotal roles 5 11.
  • The accumulation of senescent cells and their secretory phenotype further exacerbates inflammation and tissue remodeling in the aging heart 13.
  • The new study builds on these insights by spatially mapping where these inflammatory and fibrotic processes are most pronounced, supporting the idea that aging is regionally heterogeneous within the heart 1 4 11.

There is increasing recognition that regions such as the aortic root and heart valves are particularly vulnerable to age-related structural and functional changes—findings that are directly echoed in the new study’s focus on these anatomical "hotspots" 6 9 10.

  • Detailed anatomical studies show that the aortic root and valve regions are composed of multiple specialized structures, each of which can be affected differently by aging 6 9.
  • Clinical and histological evidence points to a higher prevalence of aortic valve disease, thickening, fibrosis, and scarring with age, sometimes independently of changes in the ventricular myocardium 10 6.
  • Age-related loss of distensibility in the aortic root affects valve function and may predispose to earlier structural deterioration 7.
  • The current study’s mapping approach provides new evidence that age-related inflammation and fibrosis are not distributed uniformly, but are concentrated in these vulnerable sites 6 9 10.

What are the cellular and molecular mechanisms underlying cardiac aging?

The cellular landscape of cardiac aging is complex, involving an interplay of immune cells, fibroblasts, metabolic changes, and molecular signaling pathways. The new study's identification of altered macrophage and fibroblast activity in aging heart regions is consistent with previous findings 2 3 4 13.

  • Increased numbers and altered function of macrophages and fibroblasts are hallmarks of cardiac aging, contributing to fibrosis and tissue remodeling 2 4.
  • Metabolic reprogramming, including altered glucose and lipid metabolism, and increased oxidative stress, are central to the loss of cardiac function with age 3 5.
  • The senescence-associated secretory phenotype (SASP) promotes local inflammation, and molecular hallmarks such as autophagy dysfunction, mitochondrial changes, and epigenetic alterations have been identified as therapeutic targets 13.
  • Sex differences in the molecular and cellular signatures of cardiac aging have been reported, potentially explaining some of the observed variability in disease progression between males and females 3 5.

Can interventions or diagnostics target region-specific cardiac aging?

As understanding of region-specific cardiac aging grows, so does interest in targeted interventions and diagnostics to prevent or reverse pathological changes. The concentration of age-related changes in the valves and aortic root, as found in the new study, may open the door to more personalized approaches 5 7 15.

  • Lifestyle interventions, such as exercise and dietary modification, as well as pharmacological agents targeting inflammation and cellular senescence, show promise for modulating age-related cardiac decline 5 15.
  • Non-invasive diagnostic techniques, including imaging for arterial stiffness, valve calcification, or localized fibrosis, are under development to detect early, region-specific changes and may facilitate targeted interventions 15 7.
  • Understanding the molecular and anatomical specificity of cardiac aging could help refine criteria for interventions such as valve replacement or repair in older adults 5 8.
  • The new study’s findings may inform future strategies for both early detection and prevention of localized cardiac aging processes 5 15.

Future Research Questions

While this study broadens understanding of how aging affects the heart at a regional and cellular level, several important questions remain. Future research should address the mechanisms driving region-specific changes, the clinical significance of these localized processes, and the potential for targeted interventions to preserve cardiac health in aging populations.

Research Question Relevance
How do region-specific inflammatory and fibrotic changes in the heart contribute to clinical cardiovascular disease risk? Understanding the clinical impact of localized aging processes could help identify individuals at highest risk and inform targeted prevention or treatment strategies 1 4 10.
What molecular signals drive the accumulation of macrophages and fibroblasts in the aortic root and valves during aging? Identifying upstream regulators could reveal new therapeutic targets to slow or reverse region-specific inflammation and fibrosis 2 4 13.
Can lifestyle or pharmacologic interventions selectively prevent or reverse aging-related changes in the valves and aortic root? Research into targeted interventions may enable more effective prevention of valve disease and heart failure in older adults 5 15.
Are the region-specific patterns of cardiac aging observed in mice also present in humans, and how do they vary by sex? Translational studies are needed to confirm the relevance of these findings in human populations and to explore potential sex differences in anatomical and molecular aging patterns 3 5 14.
What are the earliest detectable biomarkers of inflamm-aging in specific cardiac regions, and can they be used for early diagnosis or risk stratification? Early detection of localized inflammatory or fibrotic changes could enable preemptive interventions and improve outcomes for aging individuals 11 13 15.

Sources